Amundi Asset Management US’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $722K | Hold |
6,100
| – | – | ﹤0.01% | 1284 |
|
|
2020
Q4 | $720K | Buy |
6,100
+3,400
| +126% | +$401K | ﹤0.01% | 1249 |
|
|
2020
Q3 | $300K | Hold |
2,700
| – | – | ﹤0.01% | 1312 |
|
|
2020
Q2 | $276K | Hold |
2,700
| – | – | ﹤0.01% | 1321 |
|
|
2020
Q1 | $291K | Hold |
2,700
| – | – | ﹤0.01% | 1267 |
|
|
2019
Q4 | $314K | Hold |
2,700
| – | – | ﹤0.01% | 1378 |
|
|
2019
Q3 | $309K | Buy |
2,700
+600
| +29% | +$68.7K | ﹤0.01% | 1369 |
|
|
2019
Q2 | $200K | Hold |
2,100
| – | – | ﹤0.01% | 1452 |
|
|
2019
Q1 | $192K | Hold |
2,100
| – | – | ﹤0.01% | 1417 |
|
|
2018
Q4 | $159 | Buy |
2,100
+933
| +80% | +$71 | ﹤0.01% | 1402 |
|
|
2018
Q3 | $93K | Buy |
1,167
+800
| +218% | +$63.8K | ﹤0.01% | 1480 |
|
|
2018
Q2 | $36K | Sell |
367
-13,390
| -97% | -$1.31M | ﹤0.01% | 1523 |
|
|
2018
Q1 | $1.12M | Sell |
13,757
-29,745
| -68% | -$2.41M | ﹤0.01% | 1171 |
|
|
2017
Q4 | $3.43M | Buy |
+43,502
| New | +$3.43M | 0.01% | 950 |
|
|
2015
Q1 | – | Sell |
-5,525
| Closed | -$371K | – | 651 |
|
|
2014
Q4 | $371K | Buy |
+5,525
| New | +$371K | ﹤0.01% | 596 |
|